Burnham Institute, La Jolla
Reports advance knowledge in HIV/AIDS Pathogenesis research
Published in AIDS Weekly and Law, January 19th, 2006
Study 1: CXCR4 TM residue mutations selectively decrease HIV-1-mediated cell fusion but not the binding activity of SDF-1alpha.
According to recently published research from the United States, "The entry of human immunodeficiency virus type 1 (HIV-1) into the cell is initiated by the interaction of the viral surface envelope protein with two cell surface components of the target cell, CD4 and a chemokine coreceptor, usually CXCR4 or CCR5. The natural ligand of CXCR4 is stromal cell-derived factor 1 alpha (SDF-1 alpha).
"Whereas the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
Source: AIDS Weekly and Law (2006-01-19)
More Articles from AIDS Weekly and Law
- Dana Farber Cancer Institute, Boston
Schistosoma mansoni infection promotes simian-HIV clade C replication - Dana Farber Cancer Institute, Boston
CD4 T cells physically lost with sustained HIV replication - Roche
Data show combination of protease inhibitor plus Fuzeon most effective in viral suppression in HIV - Tanox, Inc.
Additional phase II data support further development of HIV therapy - Brighton & Sussex University Hospital
HIV infection significantly reduces survival rate of patients with tuberculous meningitis - Calypte Biomedical Corporation
Use of HIV-1 BED Incidence EIA test expanded by use of dried blood spots - More from this issue of AIDS Weekly and Law
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
